Introduction: Understanding Knee Osteoarthritis and Current Challenges

Knee osteoarthritis (OA) is a common condition affecting millions around the world. It happens when the cartilage that cushions the knee joint gradually wears away, causing pain, stiffness, and difficulty moving. These symptoms can significantly disrupt everyday activities and overall quality of life. Traditional treatments—such as painkillers, physiotherapy, and sometimes surgery—mostly focus on managing symptoms rather than tackling the root causes of joint damage. For many with mild-to-moderate OA, these approaches often provide only limited or short-lived relief, emphasising the need for fresh treatment options.

One innovative development is Arthrosamid, an injectable hydrogel designed to support the knee joint and improve function. In this article, we’ll explain how Arthrosamid works, who it might help most, and how it compares with other non-surgical therapies for knee OA.

The Science Behind Arthrosamid: How It Works

Arthrosamid is a water-based, non-biodegradable gel injected directly into the synovial membrane—the soft lining inside the knee joint. You can think of it like adding an extra, cushioning gel layer inside the joint. This layer acts as a shock absorber, reducing friction between bones and helping to protect worn cartilage surfaces.

By lowering friction, Arthrosamid not only eases pain but also supports smoother, more comfortable movement. It also helps reduce inflammation, which is a key contributor to swelling and discomfort in OA. Unlike some treatments that are quickly broken down by the body, this hydrogel remains stable within the joint for a long time.

Most patients notice improvements anywhere from 24 hours up to a few weeks after the injection. And the benefits can last two to three years—a significant advantage over more traditional injections like corticosteroids or hyaluronic acid, which often wear off within months.

Who Benefits Most from Arthrosamid?

Arthrosamid tends to suit people with mild-to-moderate knee osteoarthritis who haven’t found enough relief with standard treatments, or who want to avoid surgery. To ensure the injection is the right fit, careful clinical evaluation is necessary.

Experts such as Professor Paul Lee, an experienced consultant in cartilage repair and rehabilitation, support tailored, evidence-based treatment decisions. His clinic, MSK Doctors, provides a professional and caring environment where patients receive personalised care throughout their treatment journey, including innovative options like Arthrosamid.

How Arthrosamid Compares with Other Treatments

Arthrosamid stands apart from more familiar injectable therapies like corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and stem cell injections. Each of these has unique benefits and limitations.

For example, PRP has been shown to “reduce pain, improve quality of life and functional scores even at midterm of 6 months follow-up” but without any detectable changes on imaging scans (Moretti et al., 2022). Stem cell therapies are also promising; one major review concluded that “MSC therapy could serve as an effective and safe therapy for clinical application in OA treatment,” with “significant improvements in symptoms” over six months (Song et al., 2020).

Emerging treatments targeting the biological pathways of OA go even further. A recent study showed that a drug called lorecivivint “shows potential to modify joint structure and improve symptoms by regulating cellular processes involved in cartilage repair and inflammation” (Deshmukh et al., 2019).

Despite these advances, many treatments offer only short- or medium-term relief or are still being researched. In contrast, Arthrosamid’s hydrogel cushions the joint continuously for years, providing longer-lasting symptom control with minimal disruption to daily life.

The safety profile of Arthrosamid is favourable, typically causing only mild, temporary soreness near the injection site. This compares well with other options that may require repeated treatments or carry risk of flare-ups. Still, patients should always be monitored by orthopaedic specialists to ensure treatment remains effective and safe.

Making Informed Choices About Knee Osteoarthritis Care

Arthrosamid represents an exciting step forward in managing knee osteoarthritis. Unlike treatments that simply mask symptoms, it supports joint function and offers potential for longer-lasting relief.

If you have knee OA, speaking to specialists such as Professor Paul Lee at MSK Doctors can provide valuable personalised advice. An expert evaluation can help you understand if Arthrosamid might be suitable.

Ultimately, managing osteoarthritis well requires a proactive and comprehensive approach—regular check-ups, healthy lifestyle choices, and access to innovative therapies all help people maintain mobility and quality of life.

If you’re considering Arthrosamid for knee osteoarthritis, it’s essential to seek professional medical guidance to find the best treatment plan for you.

References

• Moretti, L., Maccagnano, G., Coviello, M., Cassano, G., Franchini, A., Laneve, A., & Moretti, B. (2022). Platelet Rich Plasma Injections for Knee Osteoarthritis Treatment: A Prospective Clinical Study. Journal of Clinical Medicine, 11(9), 2640. https://doi.org/10.3390/jcm11092640
• Song, Y., Zhang, J., Xu, H., Lin, Z., Chang, H., Liu, W., & Kong, L. (2020). Mesenchymal stem cells in knee osteoarthritis treatment: A systematic review and meta-analysis. Journal of Orthopaedic Translation, 24, 121–130. https://doi.org/10.1016/j.jot.2020.03.015
• Deshmukh, V., O’green, A., Bossard, C., Seo, T., Lamangan, L., Ibanez, M., ... Yazici, Y. (2019). Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Osteoarthritis and Cartilage, 27(9), 1342–1350. https://doi.org/10.1016/j.joca.2019.05.006